Potent antihypertensive action of dietary flaxseed in hypertensive patients

Hypertension

Volumn 62, Issue 6, 2013, Pages 1081-1089

  Rodriguez Leyva, Delfin ^a   Weighell, Wendy ^b   Edel, Andrea L ^b   Lavallee, Renee ^b   Dibrov, Elena ^b   Pinneker, Reinhold ^b   Maddaford, Thane G ^b   Ramjiawan, Bram ^b   Aliani, Michel ^b   Guzman, Randolph ^b   Pierce, Grant N ^b  

^a Cardiovascular Research Division   (Cuba)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha linolenic acid; Flax; Hypertension; Myocardial infarction; Peripheral arterial disease; Polyunsaturated fatty acid; Stroke

Indexed keywords

DOCOSAHEXAENOIC ACID; ENTERODIOL; ENTEROLACTONE; ICOSAPENTAENOIC ACID; LIGNAN; LINOLENIC ACID; OMEGA 3 FATTY ACID; PLACEBO; ANTIHYPERTENSIVE AGENT; PLANT MEDICINAL PRODUCT; POLYUNSATURATED FATTY ACID;

AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DOUBLE BLIND PROCEDURE; FOOD INTAKE; HUMAN; HYPERTENSION; LINSEED; MAJOR CLINICAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD; BLOOD PRESSURE; DIET; DRUG EFFECTS; FEMALE; FLAX; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT SEED; TREATMENT OUTCOME; VERY ELDERLY; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART INFARCTION;

AGED; AGED, 80 AND OVER; ALPHA-LINOLENIC ACID; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIET; DOUBLE-BLIND METHOD; FEMALE; FLAX; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; SEEDS; TREATMENT OUTCOME;

ALPHA LINOLENIC ACID; FLAX; HYPERTENSION; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; POLYUNSATURATED FATTY ACID; STROKE;

EID: 84891612854     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02094     Document Type: Article

References (38)

1. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:CR403-409.
2. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
4. Lloyd-Jones D, Adams RJ, Brown TM, et al; Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
5. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U. S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
6. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
7. Willet, WC. Potential benefits of preventative nutrition. In: Bendich A, Deckelbaum RJ, eds. Preventive Nutrition: The Comprehensive Guide for Health Professionals. Totowa, NJ: Humana Press, 1999:423-441.
8. Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA. Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1996;94:2417-2423.
9. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132:69-76.
10. Dupasquier CM, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JS, Moghadasian MM, Lukas A, Pierce GN. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol. 2006;291:H2987-H2996.
11. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol. 2007;293:H2394- H2402.
12. Bassett CM, McCullough RS, Edel AL, Patenaude A, LaVallee RK, Pierce GN. The α-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am J Physiol Heart Circ Physiol. 2011;301:H2220-H2226.
13. Ander BP, Weber AR, Rampersad PP, Gilchrist JS, Pierce GN, Lukas A. Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic Rabbits. J Nutr. 2004;134:3250-3256.
14. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
15. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 1994;72:128-132.
16. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997;96:44-49.
17. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: crosssectional study. Atherosclerosis. 2004;172:95-105.
18. Leyva DR, Zahradka P, Ramjiawan B, Guzman R, Aliani M, Pierce GN. The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial. Contemp Clin Trials. 2011;32:724-730.
19. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile of muffins and snack bars. Food Res Int. 2011;44:2489-2496.
20. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile and acceptability of bagels. J Food Sci. 2012;77:S62-S70.
21. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
22. Edel AL, Aliani M, Pierce GN. Supported liquid extraction in the quantitation of plasma enterolignans using isotope dilution GC/MS with application to flaxseed consumption in healthy adults. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;912:24-32.
23. Aggarwal S, Loomba RS, Arora R. Preventive aspects in peripheral artery disease. Ther Adv Cardiovasc Dis. 2012;6:53-70.
24. Patenaude A, Rodriguez-Leyva D, Edel AL, Dibrov E, Dupasquier CM, Austria JA, Richard MN, Chahine MN, Malcolmson LJ, Pierce GN. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr. 2009;63:1123-1129.
25. Schoenberger JA. The therapeutic trials. In: Braunwald E, ed. Atlas of Heart Disease. Vol I. Hypertension: Mechanisms and Therapy. Philadelphia, PA: Current Medicine Publishers; 1995:8. 1-8.16.
26. Weder AB. Pathogenesis of hypertension: genetic and environmental factors. In: Braunwald E, ed. Atlas of Heart Disease. Vol I. Hypertension: Mechanisms and Therapy, Philadelphia, PA: Current Medicine Publishers, 1995:1.1-1.25.
27. Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, Lambers Heerspink HJ, Perkovic V, Huxley R, Arima H, Patel A, Chalmers J, Woodward M, MacMahon S, Neal B; Blood Pressure Lowering Treatment Trialists' Collaboration. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: metaanalysis of randomized trials. J Hypertens. 2011;29:4-16.
28. Dodin S, Lemay A, Jacques H, Légaré F, Forest JC, Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab. 2005;90:1390-1397.
29. Stuglin C, Prasad K. Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther. 2005;10:23-27.
30. Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr. 1999;69:395-402.
31. Djoussé L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension. 2005;45:368-373.
32. Bemelmans WJ, Muskiet FA, Feskens EJ, de Vries JH, Broer J, May JF, Jong BM. Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. Eur J Clin Nutr. 2000;54:865-871.
33. Takeuchi H, Sakurai C, Noda R, Sekine S, Murano Y, Wanaka K, Kasai M, Watanabe S, Aoyama T, Kondo K. Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects with high-normal blood pressure and mild hypertension. J Oleo Sci. 2007;56:347-360.
34. Montezano AC, Touyz RM. Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol. 2012;28:288-295.
35. Cornish SM, Chilibeck PD, Paus-Jennsen L, Biem HJ, Khozani T, Senanayake V, Vatanparast H, Little JP, Whiting SJ, Pahwa P. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab. 2009;34:89-98.
36. Streppel MT, Arends LR, van't Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebocontrolled trials. Arch Intern Med. 2005;165:150-156.
37. Udenigwe CC, Aluko RE. Antioxidant and angiotensin converting enzyme-inhibitory properties of a flaxseed protein-derived high Fischer ratio peptide mixture. J Agric Food Chem. 2010;58:4762-4768.
38. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.